BSECompany Update▲ PositiveOrder Win17 Aug 2026
Balu Forge Industries Ltd
Please find enclosed the Press Release regaring receipt of multi month contract for 155mm ERFB BB/BT Shells.
Balu Forge Industries Ltd has received a multi-month contract for 155mm ERFB BB/BT Shells from an Indian ammunition player, marking a significant milestone in the indigenisation of critical defence technologies.
NSEGeneral Updates▲ PositiveOrder Win17 Aug 2026
Balu Forge Industries Limited
General Updates
Balu Forge Industries Limited has received a multi-month contract for 155mm ERFB BB/BT Shells in the Defence Sector.
BSECompany Update▲ PositiveResults17 Aug 2026
Meghna Infracon Infrastructure Ltd
Please find enclosed press release.
Meghna Infracon Infrastructure Ltd has announced its Q1 FY27 performance, with revenue at Rs. 84.38 million, EBITDA at Rs. 9.30 million, and PAT at Rs. 5.67 million. The company continues to focus on operational excellence, timely delivery, and customer-centric development.
BSECompany Update▲ PositiveMgmt Change17 Aug 2026
Genesys International Corporation Ltd
Please find attached a copy of press release titled " Genesys International appoints Nikhil Alulkar as Chief Executive officer"
Genesys International Corporation Ltd has appointed Nikhil Alulkar as its Chief Executive Officer, marking an important step in the company's evolution as it expands beyond its established government business and accelerates enterprise adoption and scaling of its AI-enabled mapping and Digital Twin platforms.
BSECompany Update▲ PositiveResults17 Aug 2026
Veerhealth Care Ltd
Please find thew attached press release
Veerhealth Care Ltd reported a 388.13% YoY growth in Total Revenues at ₹25.09 Crore, 233.87% YoY growth in EBITDA at ₹2.07 Crore, and 412.50% YoY growth in PAT at ₹1.23 Crore for Q1FY27. The company also announced orders from New York-based Company, FMCG company, and a network of pharmacies and healthcare company.
NSEInvestor Presentation▲ PositiveResults17 Aug 2026
Schneider Electric Infrastructure Limited
Investor Presentation
Schneider Electric Infrastructure Limited has informed the Exchange about Investor Presentation, which includes unaudited financial results for the 1st quarter ended June 30, 2026. The company has highlighted its growth engines, strategic pillars, and wins in various segments, including semiconductors, data centers, and renewable energy. The presentation also emphasizes the company's ESG commitments and financial performance, with a record quarterly order intake.
NSEGeneral Updates▲ PositiveRegulatory17 Aug 2026
Sun Pharmaceutical Industries Limited
General Updates
Sun Pharmaceutical Industries Limited has received a favourable court decision in the Lipitor antitrust litigation, with the US Court of Appeals affirming the order granting summary judgment in favour of the company and its subsidiaries, and denying class certification to the plaintiffs.
BSECompany Update▲ PositiveLitigation17 Aug 2026
Sun Pharmaceutical Industries Ltd
Update on Lipitor Antitrust Litigation
Sun Pharmaceutical Industries Ltd has been a defendant in antitrust litigation in the US related to a 2008 patent litigation settlement agreement with Pfizer concerning generic Lipitor. The US Court of Appeals has affirmed the order in favour of the Company, bringing the litigation substantially to a close.
BSECompany Update▲ PositiveResults17 Aug 2026
Schneider Electric Infrastructure Ltd
Please find enclosed herewith the investor presentation for earnings quarterly calls for Q1- June 30, 2026 on financial results of the Company.
Schneider Electric Infrastructure Ltd has released an investor presentation for Q1 FY 26-27, showcasing its financial results and strategic growth engines. The company has achieved a highest-ever quarterly order intake and continues to drive growth through its digital wins, ESG commitments, and strategic foothold in various industry segments.
BSECompany Update▲ PositiveResults17 Aug 2026
Kotak Mahindra Bank Ltd
Intimation attached
Kotak Mahindra Bank Ltd has made an investor presentation available on its website, as per Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The presentation highlights the bank's strong fundamentals, including a robust balance sheet, healthy FX reserves, and a constructive outlook for FY27. The bank's management team and board of directors are also showcased in the presentation.
BSECompany Update▲ PositiveResults16 Aug 2026
Embassy Developments Ltd
Please find attached herewith the transcript of earnings conference call held on August 11, 2026.
Embassy Developments Ltd has announced the transcript of its Q1 FY27 earnings conference call, highlighting a 338% year-on-year increase in presales to INR868 crores and a 54% increase in collections to INR496 crores.
NSEPress Release▲ PositiveResults16 Aug 2026
Suraj Estate Developers Limited
Press Release
Suraj Estate Developers Limited has announced its unaudited financial results for the quarter ended June 30, 2026, with a 74% year-over-year increase in sales value and sales area, and a 10% increase in total income. The company has also acquired a land parcel in Dadar (West) with a development potential of ~0.18 lakh sq ft and estimated GDV of ~Rs.100 crore.
BSECompany Update▲ PositiveResults16 Aug 2026
Suraj Estate Developers Ltd
Press Release on Unaudited Financial Results for the quarter ended June 30, 2026
Suraj Estate Developers Ltd reported unaudited financial results for Q1FY27, with sales value and sales area increasing 74% YoY to Rs.141 crore and 28,834 sq. ft., respectively. Collections stood at Rs.86 crore, reflecting healthy customer demand and execution. The company acquired a land parcel in Dadar (West) with an estimated GDV potential of ~Rs.100 crore, strengthening its project pipeline and presence in South-Central Mumbai.
BSECompany Update▲ PositiveResults16 Aug 2026
WSFx Global Pay Ltd
InvestorPresentation for the Quarter ended June 30, 2026.
WSFx Global Pay Ltd has released its Investor Presentation for Q1 FY 2026-27, showcasing strong YoY growth, deeper institutional distribution, and a structural regulatory opportunity. Gross turnover rose 36.24% YoY to ₹1,490.75 Cr, PBT rose 255.63% YoY to ₹0.583 Cr, and revenue from operations increased 27.57% YoY to ₹23.23 Cr. The company has expanded its AD-II scope, enabling Forex Correspondent framework, and has shown progression reflecting operating leverage.
BSECompany Update▲ PositiveResults16 Aug 2026
WSFx Global Pay Ltd
InvestorPresentation for the Quarter ended June 30, 2026.
WSFx Global Pay Ltd has announced its Q1 FY 2026-27 results, showing strong YoY growth in gross turnover, revenue from operations, and PBT, driven by increased institutional distribution and a structural regulatory opportunity.
NSEInvestor Presentation▲ PositiveResults16 Aug 2026
Rishabh Instruments Limited
Investor Presentation
Rishabh Instruments Limited has informed the Exchange about Investor Presentation for Q1FY27, with consolidated revenue growing 4.2% YoY and consolidated EBITDA increasing 17.3% YoY.
BSECompany Update▲ PositiveResults16 Aug 2026
Rishabh Instruments Ltd
As per Attachment
Rishabh Instruments Ltd has announced its Q1FY27 results, with consolidated revenue growing 4.2% YoY and consolidated EBITDA increasing 17.3% YoY. The company has reported a robust 34.0% YoY growth in the EEI segment and maintained EBITDA margins of ~24%. The management has highlighted the industry outlook as structurally attractive, driven by investments in electrification, grid modernization, renewable energy, and industrial automation.
BSECompany Update▲ PositiveResults16 Aug 2026
Novelix Pharmaceuticals Ltd
Submission of Newspaper Publication of the financial results for the quarter ended 30th June, 2026.
Novelix Pharmaceuticals Ltd has submitted its unaudited financial results for the quarter ended 30th June, 2026, showing a net profit of Rs. 352.48 crore and earnings per share of Rs. 2.32.
BSECompany Update▲ PositiveResults16 Aug 2026
Viyash Scientific Ltd
Earning call Transcript Q1 FY 2026-27
Viyash Scientific Ltd announced its Q1 FY 2026-27 earnings, with revenue from operations growing 20% YoY to Rs. 946 crores, EBITDA growing 59% YoY to Rs. 205 crores, and PAT more than doubling to Rs. 79 crores. The company's balance sheet shows improvement, with net debt decreasing to Rs. 86 crores and net debt to EBITDA ratio improving to 0.1x.
NSEAnalysts/Institutional Investor Meet/Con. Call Updates▲ PositiveResults16 Aug 2026
Viyash Scientific Limited
Analysts/Institutional Investor Meet/Con. Call Updates
Viyash Scientific Limited has announced its Q1 FY'27 earnings, with revenue from operations growing 20% year-on-year to Rs. 946 crores, EBITDA increasing 59% to Rs. 205 crores, and profit after tax more than doubling to Rs. 79 crores. The company's balance sheet has improved, with net debt decreasing to Rs. 86 crores and net debt to EBITDA ratio reducing to 0.1x.